NCT05752175View on ClinicalTrials.gov

Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection

PHASE2CompletedINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

May 9, 2023

Study Completion Date

July 3, 2023

Conditions

COVID-19 Infection

Interventions

DRUG

WPV01

WPV01 tablets

DRUG

Placebo

Placebo tablets

Trial Locations (1)

Unknown

Shulan(Hangzhou) Hospital, Hangzhou

All Listed Sponsors

lead

Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

INDUSTRY